CME Group Gestione
Criteri Gestione verificati 3/4
CME Group Il CEO è Terry Duffy, nominato in Nov2016, e ha un mandato di 9.83 anni. la retribuzione annua totale è $ 23.39M, composta da 8.5% di stipendio e 91.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.015% delle azioni della società, per un valore di $ 15.25M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 9.8 anni e 18.2 anni.
Informazioni chiave
Terry Duffy
Amministratore delegato
US$23.4m
Compenso totale
| Percentuale dello stipendio del CEO | 8.55% |
| Mandato del CEO | 9.8yrs |
| Proprietà del CEO | 0.02% |
| Durata media del management | 9.8yrs |
| Durata media del Consiglio di amministrazione | 18.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Seeking Alpha • Aug 25
CME Group: The Price Stands Still, But The Growth Engines Accelerate
Summary CME Group remains a Buy, driven by robust volumes, an expanding fixed-income ecosystem, and product innovation, despite a full valuation. CME's Q2 2026 saw record revenues, strong margins near 70%, and notable growth in international and retail trading volumes. Key catalysts include Treasury Link integration, 24/7 trading, Compute futures, and regulatory tailwinds in clearing requirements. Competition from perpetual futures and a premium valuation at 21x forward earnings temper near-term upside, but long-term growth and capital returns support the rating. Read the full article on Seeking Alpha
Aggiornamento narrativa • Jul 28
CME: Perpetual Futures Dispute And New Contracts Will Shape Earnings Profile
The analyst fair value estimate for CME Group has been trimmed by about $6.64 to $282.36, as analysts balance slightly higher projected revenue growth with lower profit margin assumptions and a modestly reduced future P/E multiple following a mix of recent target cuts and increases across the Street. Analyst Commentary Recent research on CME Group shows a split view, with some firms lifting price targets and ratings while others trim expectations and flag competitive threats.Aggiornamento narrativa • Jul 09
CME: Crypto Perpetual Futures Dispute Will Reshape Long Term Earnings Power
The analyst price target for CME Group has been trimmed by about $14 to reflect slightly softer revenue growth assumptions, a modestly higher discount rate, and lower future P/E multiples that many analysts link to competitive concerns around perpetual futures, despite broadly constructive views on the core franchise. Analyst Commentary Recent research on CME Group highlights a split view, with some analysts seeing attractive upside after the share pullback and others focusing on competitive threats and pricing pressure.Aggiornamento narrativa • Jun 24
CME: Crypto Perpetual Futures Dispute Will Shape Future Earnings Power
The analyst price target for CME Group has shifted slightly lower, with fair value moving from about $306.47 to $302.60 as analysts weigh ongoing concerns around perpetual futures and potential multiple compression against views that recent share weakness and structural demand drivers still support an attractive long term setup. Analyst Commentary Recent research on CME Group shows a split between bullish analysts who see the recent pullback and product portfolio as supportive for long term value, and more cautious voices focused on competitive threats from perpetual futures and the potential impact on valuation multiples.Articolo di analisi • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...Aggiornamento narrativa • Jun 05
CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.Aggiornamento narrativa • May 15
CME: Mixed Street Views And New Markets Will Shape Future Earnings Power
Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.Aggiornamento narrativa • Apr 27
CME: Volatile Street Views And New Futures Will Shape Trading Mix
Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.Aggiornamento narrativa • Apr 11
CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes
The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.Aggiornamento narrativa • Mar 26
CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix
Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.Aggiornamento narrativa • Mar 11
CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook
Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.Aggiornamento narrativa • Feb 25
CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook
The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.Aggiornamento narrativa • Feb 10
CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook
The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.Aggiornamento narrativa • Jan 27
CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook
The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.Aggiornamento narrativa • Jan 12
CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook
Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.Aggiornamento narrativa • Dec 27
CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks
Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.Aggiornamento narrativa • Dec 13
CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility
Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.Aggiornamento narrativa • Nov 16
CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead
The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Utili della società |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | US$4b |
| Mar 31 2026 | n/a | n/a | US$4b |
| Dec 31 2025 | US$23m | US$2m | US$4b |
| Sep 30 2025 | n/a | n/a | US$4b |
| Jun 30 2025 | n/a | n/a | US$4b |
| Mar 31 2025 | n/a | n/a | US$4b |
| Dec 31 2024 | US$24m | US$2m | US$3b |
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$23m | US$2m | US$3b |
| Sep 30 2023 | n/a | n/a | US$3b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$3b |
| Dec 31 2022 | US$23m | US$2m | US$3b |
| Sep 30 2022 | n/a | n/a | US$3b |
| Jun 30 2022 | n/a | n/a | US$3b |
| Mar 31 2022 | n/a | n/a | US$3b |
| Dec 31 2021 | US$23m | US$2m | US$3b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$16m | US$2m | US$2b |
| Sep 30 2020 | n/a | n/a | US$2b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$12m | US$2m | US$2b |
Compensazione vs Mercato: La retribuzione totale di Terry ($USD 23.39M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 14.76M ).
Compensazione vs guadagni: La retribuzione di Terry è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Terry Duffy (68 yo)
9.8yrs
Mandato
US$23,394,854
Compensazione
Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group Inc., the world’s leading derivatives marketplace since November 2016. Mr. Duffy is the Chief Executiv...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman & CEO | 9.8yrs | US$23.39m | 0.015% $ 15.2m | |
| Senior MD | 3.4yrs | US$4.75m | 0.0066% $ 6.6m | |
| Chief Information Officer | 4.6yrs | US$3.38m | 0.0066% $ 6.5m | |
| Senior MD & Global Head of Commodities Markets | 16.9yrs | US$3.39m | 0.0087% $ 8.6m | |
| Senior MD & Chief Commercial Officer | 19.7yrs | US$3.38m | 0.0084% $ 8.2m | |
| Senior MD | 1.8yrs | Nessun dato | 0.0039% $ 3.8m | |
| MD & Chief Accounting Officer | 11.6yrs | Nessun dato | 0.0071% $ 7.0m | |
| Investor Contact | no data | Nessun dato | Nessun dato | |
| Senior MD & General Counsel | 3.9yrs | Nessun dato | 0.0020% $ 2.0m | |
| Senior Managing Director of Corporate Marketing & Communications | 19.6yrs | Nessun dato | Nessun dato | |
| Senior MD & Chief Human Resources Officer | 19.1yrs | Nessun dato | 0.0077% $ 7.6m | |
| Chief Transformation Officer | 6.7yrs | Nessun dato | 0.0052% $ 5.2m |
9.8yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di CME è esperto e expertise (durata media dell'incarico 9.8 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman & CEO | 31.7yrs | US$23.39m | 0.015% $ 15.2m | |
| Independent Director | 18.1yrs | US$335.67k | 0.00093% $ 916.5k | |
| Independent Director | 32.7yrs | US$288.50k | 0.0071% $ 7.0m | |
| Independent Director | 29.7yrs | US$311.25k | 0.073% $ 72.4m | |
| Independent Director | 26.7yrs | US$301.25k | 0.020% $ 19.4m | |
| Independent Director | 6.3yrs | US$269.25k | 0.012% $ 12.0m | |
| Independent Director | 19.2yrs | US$337.84k | 0.0020% $ 1.9m | |
| Independent Director | 18.3yrs | US$316.25k | 0.0033% $ 3.2m | |
| Independent Director | 8.3yrs | US$312.25k | 0.036% $ 35.0m | |
| Independent Director | 7.3yrs | US$301.25k | 0.0014% $ 1.3m | |
| Independent Director | 7.3yrs | US$313.25k | 0.0012% $ 1.2m | |
| Independent Director | 6.3yrs | US$292.84k | 0.0013% $ 1.3m |
18.2yrs
Durata media
68.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di CME è composto da personale esperto e esperto (durata media dell'incarico 18.2 anni).
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/11 21:39 |
| Prezzo dell'azione a fine giornata | 2026/09/11 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
CME Group Inc. è coperta da 32 analisti. 13 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Stephen Biggar | Argus Research Company |
| Benjamin Budish | Barclays |
| Roger Freeman | Barclays |